DK1454992T3 - Anaplastisk lymfomakinaseassay, reagenser og sammensætninger deraf - Google Patents
Anaplastisk lymfomakinaseassay, reagenser og sammensætninger derafInfo
- Publication number
- DK1454992T3 DK1454992T3 DK03005186T DK03005186T DK1454992T3 DK 1454992 T3 DK1454992 T3 DK 1454992T3 DK 03005186 T DK03005186 T DK 03005186T DK 03005186 T DK03005186 T DK 03005186T DK 1454992 T3 DK1454992 T3 DK 1454992T3
- Authority
- DK
- Denmark
- Prior art keywords
- reagents
- compositions
- kinase assay
- anaplastic lymphoma
- lymphoma kinase
- Prior art date
Links
- 102100033793 ALK tyrosine kinase receptor Human genes 0.000 title abstract 3
- 239000003153 chemical reaction reagent Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 101710168331 ALK tyrosine kinase receptor Proteins 0.000 title 1
- 238000000021 kinase assay Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Endocrinology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03005186A EP1454992B1 (en) | 2003-03-07 | 2003-03-07 | Anaplastic lymphoma kinase assay, reagents and compositions thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1454992T3 true DK1454992T3 (da) | 2006-10-02 |
Family
ID=32798804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03005186T DK1454992T3 (da) | 2003-03-07 | 2003-03-07 | Anaplastisk lymfomakinaseassay, reagenser og sammensætninger deraf |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20070031907A1 (da) |
| EP (1) | EP1454992B1 (da) |
| JP (1) | JP2006519800A (da) |
| CN (1) | CN100345978C (da) |
| AT (1) | ATE328112T1 (da) |
| CA (1) | CA2518094A1 (da) |
| CY (1) | CY1106115T1 (da) |
| DE (1) | DE60305634T2 (da) |
| DK (1) | DK1454992T3 (da) |
| ES (1) | ES2263862T3 (da) |
| IL (1) | IL170669A0 (da) |
| PT (1) | PT1454992E (da) |
| SI (1) | SI1454992T1 (da) |
| WO (1) | WO2004079326A2 (da) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2447359B1 (en) | 2006-04-14 | 2015-11-04 | Cell Signaling Technology, Inc. | Gene defects and mutant ALK kinase in human solid tumors |
| US8168383B2 (en) | 2006-04-14 | 2012-05-01 | Cell Signaling Technology, Inc. | Gene defects and mutant ALK kinase in human solid tumors |
| EP2107054A1 (en) | 2008-04-01 | 2009-10-07 | Università Degli Studi Di Milano - Bicocca | Antiproliferative compounds and therapeutic uses thereof |
| CA2722326A1 (en) | 2008-04-24 | 2009-10-29 | Incyte Corporation | Macrocyclic compounds and their use as kinase inhibitors |
| EP2161271A1 (en) | 2008-09-08 | 2010-03-10 | Università Degli Studi Di Milano - Bicocca | Alpha-carboline inhibitors of NMP-ALK, RET, and Bcr-Abl |
| US8765727B2 (en) | 2009-01-23 | 2014-07-01 | Incyte Corporation | Macrocyclic compounds and their use as kinase inhibitors |
| ES2668775T3 (es) * | 2009-06-10 | 2018-05-22 | Chugai Seiyaku Kabushiki Kaisha | Compuestos tetracíclicos |
| CN101955995B (zh) * | 2010-06-17 | 2013-06-26 | 江苏迈迪基因生物科技有限公司 | 淋巴瘤相关的融合基因的诊断试剂盒 |
| US20120101108A1 (en) | 2010-08-06 | 2012-04-26 | Cell Signaling Technology, Inc. | Anaplastic Lymphoma Kinase In Kidney Cancer |
| MX355836B (es) | 2010-08-20 | 2018-05-02 | Chugai Pharmaceutical Co Ltd | Composicion que comprende compuestos tetraciclicos. |
| EP2847353B1 (en) | 2012-05-10 | 2022-01-19 | The General Hospital Corporation | Methods for determining a nucleotide sequence |
| US10668075B2 (en) | 2012-09-25 | 2020-06-02 | Chugai Seiyaku Kabushiki Kaisha | RET inhibitor |
| KR20150118159A (ko) | 2013-02-22 | 2015-10-21 | 에프. 호프만-라 로슈 아게 | 암의 치료 방법 및 약물 내성의 예방 방법 |
| JP7016215B2 (ja) | 2014-01-27 | 2022-02-04 | ザ ジェネラル ホスピタル コーポレイション | 配列決定のために核酸を調製する方法 |
| EP3135671B1 (en) | 2014-04-25 | 2019-09-18 | Chugai Seiyaku Kabushiki Kaisha | Novel crystal of tetracyclic compound |
| WO2015163448A1 (ja) | 2014-04-25 | 2015-10-29 | 中外製薬株式会社 | 4環性化合物を高用量含有する製剤 |
| TWI831347B (zh) | 2014-08-08 | 2024-02-01 | 日商中外製藥股份有限公司 | 包含4環性化合物的非晶質體之固體分散體及製劑 |
| JP6741596B2 (ja) | 2015-01-16 | 2020-08-19 | 中外製薬株式会社 | 併用医薬 |
| JP6997773B2 (ja) | 2016-09-15 | 2022-01-18 | アーチャーディーエックス, エルエルシー | 無細胞dnaの分析用の核酸サンプル調製の方法 |
| CA3037185A1 (en) | 2016-09-15 | 2018-03-22 | ArcherDX, Inc. | Methods of nucleic acid sample preparation |
| CN110191959B (zh) | 2016-11-02 | 2024-04-09 | 阿谢尔德克斯有限责任公司 | 用于免疫组库测序的核酸样品制备方法 |
| CN112384223B (zh) | 2018-06-29 | 2024-08-27 | 中外制药株式会社 | 含有难溶性碱性药剂的药物组合物 |
| WO2020050241A1 (ja) | 2018-09-04 | 2020-03-12 | 中外製薬株式会社 | 4環性化合物の製造方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05126833A (ja) * | 1991-10-31 | 1993-05-21 | Tosoh Corp | チロシンキナ−ゼ活性の免疫化学的測定法及びそのキツト |
| CA2117913C (en) * | 1992-04-10 | 2006-05-09 | Richard J. Epstein | Activation-state-specific phosphoprotein immunodetection |
| ES2136103T3 (es) * | 1992-06-22 | 1999-11-16 | Kyowa Hakko Kogyo Kk | Procedimiento para la preparacion de derivados de estaurosporina. |
| GB9314271D0 (en) * | 1993-07-09 | 1993-08-18 | Inst Of Cancer The Research | Cell growth factor receptors |
| US6001621A (en) * | 1993-11-23 | 1999-12-14 | Genetech, Inc. | Protein tyrosine kinases |
| JP3442784B2 (ja) * | 1993-11-23 | 2003-09-02 | ジェネンテク,インコーポレイテッド | キナーゼ受容体活性化検定法 |
| US5529925A (en) * | 1993-12-03 | 1996-06-25 | St. Jude Children's Research Hospital | Nucleic acid sequences and fusion proteins present in human t(2;5) lymphoma |
| US5763198A (en) * | 1994-07-22 | 1998-06-09 | Sugen, Inc. | Screening assays for compounds |
| US5759787A (en) * | 1996-08-26 | 1998-06-02 | Tularik Inc. | Kinase assay |
| WO1998049317A2 (en) * | 1997-04-28 | 1998-11-05 | Sugen, Inc. | Diagnosis and treatment of phosphatase- 0r kinase-related disorders |
| US6806266B1 (en) * | 1999-07-13 | 2004-10-19 | Kyowa Hakko Kogyo Co., Ltd. | Staurosporin derivatives |
-
2003
- 2003-03-07 PT PT03005186T patent/PT1454992E/pt unknown
- 2003-03-07 ES ES03005186T patent/ES2263862T3/es not_active Expired - Lifetime
- 2003-03-07 SI SI200330308T patent/SI1454992T1/sl unknown
- 2003-03-07 EP EP03005186A patent/EP1454992B1/en not_active Expired - Lifetime
- 2003-03-07 DE DE60305634T patent/DE60305634T2/de not_active Expired - Fee Related
- 2003-03-07 AT AT03005186T patent/ATE328112T1/de not_active IP Right Cessation
- 2003-03-07 DK DK03005186T patent/DK1454992T3/da active
-
2004
- 2004-03-04 CN CNB2004800060187A patent/CN100345978C/zh not_active Expired - Fee Related
- 2004-03-04 CA CA002518094A patent/CA2518094A1/en not_active Abandoned
- 2004-03-04 JP JP2006504533A patent/JP2006519800A/ja active Pending
- 2004-03-04 WO PCT/EP2004/002185 patent/WO2004079326A2/en not_active Ceased
- 2004-03-04 US US10/547,842 patent/US20070031907A1/en not_active Abandoned
-
2005
- 2005-09-05 IL IL170669A patent/IL170669A0/en unknown
-
2006
- 2006-07-04 CY CY20061100923T patent/CY1106115T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004079326A2 (en) | 2004-09-16 |
| US20070031907A1 (en) | 2007-02-08 |
| CA2518094A1 (en) | 2004-09-16 |
| CY1106115T1 (el) | 2011-06-08 |
| PT1454992E (pt) | 2006-09-29 |
| WO2004079326A3 (en) | 2004-12-09 |
| DE60305634T2 (de) | 2006-09-21 |
| EP1454992B1 (en) | 2006-05-31 |
| IL170669A0 (en) | 2011-08-01 |
| DE60305634D1 (de) | 2006-07-06 |
| CN100345978C (zh) | 2007-10-31 |
| SI1454992T1 (sl) | 2006-10-31 |
| ATE328112T1 (de) | 2006-06-15 |
| CN1756850A (zh) | 2006-04-05 |
| EP1454992A1 (en) | 2004-09-08 |
| HK1068154A1 (en) | 2005-04-22 |
| ES2263862T3 (es) | 2006-12-16 |
| JP2006519800A (ja) | 2006-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1454992E (pt) | Ensaio de quinase do linfoma anaplastico, reagentes e composicoes | |
| WO2005111212A3 (en) | Biological bar code | |
| NO20005224L (no) | BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse | |
| WO2005028443A3 (en) | Protein tyrosine kinase enzyme inhibitors | |
| DK1766412T3 (da) | Sammensætninger og fremgangsmåder til kvantificering af serumglycoproteiner | |
| DE60007095D1 (de) | Calanolide zur hemmung von btk | |
| WO2005012574A3 (en) | Biological bar-code | |
| DK1706424T3 (da) | FC-region varianter | |
| ATE330038T1 (de) | Nukleinsäure-biosensor | |
| EA200501563A1 (ru) | Пролекарства ингибиторов киназы pi-3 | |
| DE602004018780D1 (de) | Inhibitoren von thienopyridin- und furopyridinkinase | |
| DK1847611T3 (da) | Rhamnose-inducerbart ekspressionssystem | |
| EP1700120A4 (en) | MARKER FOR OPTICAL NEUROMYELITIS | |
| WO2002047535A3 (en) | High throughput assay to detect inhibitors of the map kinase pathway | |
| ATE413884T1 (de) | Beta-secretase-substrat und seine verwendung | |
| WO2004050842A3 (en) | Atm kinase compositions and methods | |
| ATE494548T1 (de) | Reinigung, charakterisierung und wiederherstellung einer ubiquitin-e3-ligase | |
| DE60117591D1 (de) | Verfahren zum nachweis von serine/threonine kinase aktivität | |
| DE50309381D1 (de) | Neue pyrimidin-4,6-dicarbons urediamide zur selektiven inhibierung von kollagenasen | |
| NO20033921L (no) | Inhibitor av monoaminopptak | |
| WO2004084708A3 (en) | Finding usable portion of sigmoid curve | |
| ATE457317T1 (de) | Chemokine rezeptor | |
| DE60207833D1 (de) | Peptiddeformylase-hemmer | |
| EP1559721A4 (en) | NEW FPRL1 LIGANDS AND THEIR USE | |
| ATE430317T1 (de) | Enzymatische messung von imatinib-mesylat |